Berfin Uysal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Berfin Uysal has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Berna Aytaç Vuruşkan
Uludag Univ, Dept Pathol, Fac Med, Bursa, Turkey
2 shared publicationsFahrettin Uysal
Department of Pediatric Cardiology, Faculty of Medicine, Uludag University, Bursa, Turkey
2 shared publicationsAfig Berdeli
Molecular Medicine Laboratory and Stem Cell Department of Ege Health Science Institute Department of Pediatrics University of Ege İzmir Turkey
1 shared publication- Ahmet Midhat Elmacı
Department of Pediatric Nephrology, Konya Dr Faruk Sükan Maternity and Children Hospital, Konya, Turkey
1 shared publication - Alev Yilmaz
Division of Pediatric Nephrology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye
1 shared publication - Atilla Gemici
Department of Pediatric Nephrology, Erzurum Regional Training and Research Hospital, Erzurum, Turkey
1 shared publication
Latest Publications
- Open Access
- 29 September 2026
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 53 (10)
Obstructed Hemivagina and Ipsilateral Renal Anomaly Syndrome: A Spectrum of Clinical Presentations, Diagnostic Challenges, and Surgical Management
Background: Müllerian anomalies are congenital abnormalities of the female reproductive tract that may present with a wide range of clinical manifestations, and some forms may remain undiagnosed until adolescence or until complications develop. This study aimed to evaluate the clinical presentations, radiological findings, diagnostic challenges, and surgical management of patients with obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome treated at a tertiary referral center. Methods: The study included patients diagnosed with OHVIRA syndrome from July 17, 2019, to October 1, 2024. Following ethics committee approval, cases were categorized into four different scenarios. Scenario 1: suspected OHVIRA syndrome during infancy; Scenario 2: obstructed hemivagina with hematocolpos at puberty; Scenario 3: spontaneous fistulization of hematocolpos; and Scenario 4: pregnancy following surgical management of OHVIRA syndrome. The diagnostic approach and follow-up processes for patients in each clinical scenario were summarized. Results: Six patients were categorized into four distinct clinical scenarios according to their clinical presentations. Five patients had confirmed OHVIRA syndrome, while one patient had suspected OHVIRA syndrome based on the presence of ipsilateral renal agenesis and a cystic vaginal lesion. Clinical presentations ranged from suspected OHVIRA syndrome presenting with mucocolpos during infancy to hematocolpos at puberty, spontaneous fistulization, and successful pregnancy following previous vaginal septum resection. Pelvic ultrasonography (USG) and magnetic resonance imaging (MRI) accurately identified uterus didelphys, obstructed hemivagina and hematocolpos. We present a case of mucocolpos and a case describing the pregnancy outcome following surgery for hematocolpos. Three patients underwent vaginoscopic hematocolpos drainage, one patient was diagnosed following spontaneous fistulization of hematocolpos, and five patients had favorable clinical outcomes without recurrent obstruction during follow-up. The remaining patient, who was followed during early childhood for mucocolpos, is awaiting menarche. Conclusions: OHVIRA syndrome encompasses a broad spectrum of age-dependent clinical presentations, which can pose significant diagnostic challenges. Early recognition and individualized management based on clinical and anatomical findings are essential, with USG and MRI playing key roles in establishing the diagnosis.
- 29 September 2026
- Published by IMR Press in Clinical and Experimental Obstetrics & Gynecology
- Vol. 53 (10)
Open AccessObstructed Hemivagina and Ipsilateral Renal Anomaly Syndrome: A Spectrum of Clinical Presentations, Diagnostic Challenges, and Surgical Management
Background: Müllerian anomalies are congenital abnormalities of the female reproductive tract that may present with a wide range of clinical manifestations, and some forms may remain undiagnosed until adolescence or until complications develop. This study aimed to evaluate the clinical presentations, radiological findings, diagnostic challenges, and surgical management of patients with obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome treated at a tertiary referral center. Methods: The study included patients diagnosed with OHVIRA syndrome from July 17, 2019, to October 1, 2024. Following ethics committee approval, cases were categorized into four different scenarios. Scenario 1: suspected OHVIRA syndrome during infancy; Scenario 2: obstructed hemivagina with hematocolpos at puberty; Scenario 3: spontaneous fistulization of hematocolpos; and Scenario 4: pregnancy following surgical management of OHVIRA syndrome. The diagnostic approach and follow-up processes for patients in each clinical scenario were summarized. Results: Six patients were categorized into four distinct clinical scenarios according to their clinical presentations. Five patients had confirmed OHVIRA syndrome, while one patient had suspected OHVIRA syndrome based on the presence of ipsilateral renal agenesis and a cystic vaginal lesion. Clinical presentations ranged from suspected OHVIRA syndrome presenting with mucocolpos during infancy to hematocolpos at puberty, spontaneous fistulization, and successful pregnancy following previous vaginal septum resection. Pelvic ultrasonography (USG) and magnetic resonance imaging (MRI) accurately identified uterus didelphys, obstructed hemivagina and hematocolpos. We present a case of mucocolpos and a case describing the pregnancy outcome following surgery for hematocolpos. Three patients underwent vaginoscopic hematocolpos drainage, one patient was diagnosed following spontaneous fistulization of hematocolpos, and five patients had favorable clinical outcomes without recurrent obstruction during follow-up. The remaining patient, who was followed during early childhood for mucocolpos, is awaiting menarche. Conclusions: OHVIRA syndrome encompasses a broad spectrum of age-dependent clinical presentations, which can pose significant diagnostic challenges. Early recognition and individualized management based on clinical and anatomical findings are essential, with USG and MRI playing key roles in establishing the diagnosis.
- 28 April 2022
- Published by Springer Nature in Urolithiasis
- Vol. 50 (4) , 411-421
Comparison of infants and children with urolithiasis: a large case series
We evaluated the demographic features, etiologic risk factors, treatment strategies, and outcome of the infants and children with urolithiasis (UL). A retrospective multicenter study was conducted including 23 Pediatric Nephrology centers in Turkey. The medical records of 2513 children with UL were reviewed. One thousand, three hundred and four boys and 1209 girls (1.1:1) were reported. The mean age at diagnosis was 39.5 ± 35 months (0.4–231 months), and 1262 patients (50.2%) were in the first year of life (infants). Most of the cases with infantile UL were diagnosed incidentally. Microlithiasis (< 3 mm) was found in 794 patients (31.6%), and 64.5% of the patients with microlithiasis were infants. Stones were located in the pelvis-calyces in 63.2% (n: 1530) of the cases. The most common stone type was calcium oxalate (64.6%). Hypocitraturia was the most common metabolic risk factor (MRF) in children older than 12 months, but in infancy, hypercalciuria was more common. Fifty-five percent of the patients had received at least one medical treatment, mostly potassium citrate. At the end of a year’s follow-up, most of the patients with microlithiasis (85%) showed spontaneous remission. The rate of spontaneous stone resolution in infants was higher than in children. Spontaneous remission rate was higher in cases with MRF ( − ) stones than in MRF ( +) stones. However, remission rate with medical treatment was higher in cases with MRF ( +) stones. This study represents the results of a large series of infants and children with UL and showed that there are several differences such as underlying metabolic and anatomic abnormalities, clinical course, and stone remission rates between infants and children with urinary stone disease.
- 28 April 2022
- Published by Springer Nature in Urolithiasis
- Vol. 50 (4) , 411-421
Comparison of infants and children with urolithiasis: a large case series
We evaluated the demographic features, etiologic risk factors, treatment strategies, and outcome of the infants and children with urolithiasis (UL). A retrospective multicenter study was conducted including 23 Pediatric Nephrology centers in Turkey. The medical records of 2513 children with UL were reviewed. One thousand, three hundred and four boys and 1209 girls (1.1:1) were reported. The mean age at diagnosis was 39.5 ± 35 months (0.4–231 months), and 1262 patients (50.2%) were in the first year of life (infants). Most of the cases with infantile UL were diagnosed incidentally. Microlithiasis (< 3 mm) was found in 794 patients (31.6%), and 64.5% of the patients with microlithiasis were infants. Stones were located in the pelvis-calyces in 63.2% (n: 1530) of the cases. The most common stone type was calcium oxalate (64.6%). Hypocitraturia was the most common metabolic risk factor (MRF) in children older than 12 months, but in infancy, hypercalciuria was more common. Fifty-five percent of the patients had received at least one medical treatment, mostly potassium citrate. At the end of a year’s follow-up, most of the patients with microlithiasis (85%) showed spontaneous remission. The rate of spontaneous stone resolution in infants was higher than in children. Spontaneous remission rate was higher in cases with MRF ( − ) stones than in MRF ( +) stones. However, remission rate with medical treatment was higher in cases with MRF ( +) stones. This study represents the results of a large series of infants and children with UL and showed that there are several differences such as underlying metabolic and anatomic abnormalities, clinical course, and stone remission rates between infants and children with urinary stone disease.
- 24 April 2022
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 61 (7) , 453-460
The Prevalence of Post-COVID-19 Hypertension in Children
Coronavirus disease 2019 (COVID-19) is the greatest pandemic in a century. In this study, children with mild COVID-19 infections were evaluated at least 8 weeks after the polymerase chain reaction (PCR) test positivity, and the frequency of hypertension (HT) in these children was investigated. These results were compared to those of the control group, which consisted of 32 healthy children in the same age range as the trial group but who did not have COVID-19. This prospective multicenter study was conducted including children aged 10 to 18 years. There were 16 patients (16%) who had elevated systolic blood pressure, while 11 patients (11%) had stage-1 HT and 1 patient (1%) had stage-2 HT. It was revealed that children with COVID-19 had significantly higher systolic and diastolic blood pressures than normal healthy children. The findings of this study contribute toward increasing the understanding of the sequelae of mild COVID-19 in pediatric patients.
- 24 April 2022
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 61 (7) , 453-460
The Prevalence of Post-COVID-19 Hypertension in Children
Coronavirus disease 2019 (COVID-19) is the greatest pandemic in a century. In this study, children with mild COVID-19 infections were evaluated at least 8 weeks after the polymerase chain reaction (PCR) test positivity, and the frequency of hypertension (HT) in these children was investigated. These results were compared to those of the control group, which consisted of 32 healthy children in the same age range as the trial group but who did not have COVID-19. This prospective multicenter study was conducted including children aged 10 to 18 years. There were 16 patients (16%) who had elevated systolic blood pressure, while 11 patients (11%) had stage-1 HT and 1 patient (1%) had stage-2 HT. It was revealed that children with COVID-19 had significantly higher systolic and diastolic blood pressures than normal healthy children. The findings of this study contribute toward increasing the understanding of the sequelae of mild COVID-19 in pediatric patients.
- 1 January 2022
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 64 (4) , 781-786
Aa amyloidosis presenting with acute kidney injury, curable or not?
Background. Amyloidosis is a group of disorders with extracellular accumulation of autologous fibrillary insoluble proteins in various tissues and organs such as the kidneys, liver, spleen, heart and gastrointestinal tract leading to impairment of normal organ function. Childhood amyloidosis is an exceedingly rare entity mainly caused by familial Mediterranean fever (FMF) and the other autoinflammatory diseases such as mevalonate kinase deficiency (MKD).Case. A 16-year-old male was referred to pediatric nephrology for coincidentally discovered proteinuria. He had no significant findings on physical examination except for urochromic color. He had nephrotic range proteinuria with 109 mg/m2/h and serum creatinine was 1.35 mg/dl. Kidney biopsy was performed because of nephrotic range proteinuria with acute kidney injury. In hematoxylin-eosin-stained tissue sections, amyloid was suggested as extracellular amorphous material that is lightly eosinophilic in the glomeruli. Diagnosis was confirmed by Congo red positivity, with apple-green birefringence under polarized light. MEFV gene mutation was negative and a compound heterozygote mutation found in mevalonate kinase gene. A 6-month -trial of colchicine, enalapril, and losartan combination was not successful; Canakinumab was started thereafter. Proteinuria and creatinine decreased to 7 mg/m2/h and 0.6 mg/dl respectively 4 years after treatment. Conclusions. Amyloidosis should be considered especially in children presenting with proteinuria and with a history of recurrent fever. This report also emphasizes the efficacy of canakinumab to prevent or decelerate chronic renal failure in these patients although it does not reduce tissue deposition in long-term use.
- 1 January 2022
- Published by Hacettepe University Institute of Child Health in The Turkish Journal of Pediatrics
- Vol. 64 (4) , 781-786
Aa amyloidosis presenting with acute kidney injury, curable or not?
Background. Amyloidosis is a group of disorders with extracellular accumulation of autologous fibrillary insoluble proteins in various tissues and organs such as the kidneys, liver, spleen, heart and gastrointestinal tract leading to impairment of normal organ function. Childhood amyloidosis is an exceedingly rare entity mainly caused by familial Mediterranean fever (FMF) and the other autoinflammatory diseases such as mevalonate kinase deficiency (MKD).Case. A 16-year-old male was referred to pediatric nephrology for coincidentally discovered proteinuria. He had no significant findings on physical examination except for urochromic color. He had nephrotic range proteinuria with 109 mg/m2/h and serum creatinine was 1.35 mg/dl. Kidney biopsy was performed because of nephrotic range proteinuria with acute kidney injury. In hematoxylin-eosin-stained tissue sections, amyloid was suggested as extracellular amorphous material that is lightly eosinophilic in the glomeruli. Diagnosis was confirmed by Congo red positivity, with apple-green birefringence under polarized light. MEFV gene mutation was negative and a compound heterozygote mutation found in mevalonate kinase gene. A 6-month -trial of colchicine, enalapril, and losartan combination was not successful; Canakinumab was started thereafter. Proteinuria and creatinine decreased to 7 mg/m2/h and 0.6 mg/dl respectively 4 years after treatment. Conclusions. Amyloidosis should be considered especially in children presenting with proteinuria and with a history of recurrent fever. This report also emphasizes the efficacy of canakinumab to prevent or decelerate chronic renal failure in these patients although it does not reduce tissue deposition in long-term use.
- Open Access
- 25 August 2021
- Published by Istanbul University in Experimed
- Vol. 11 (2) , 102-112
Aşırı Düşük Doğum Ağırlıklı Prematüre Çocukların Okul Öncesi Dönemde Dünya Sağlık Örgütü Çocuk ve Ergenlerde Uluslararası İşlevsellik Sınıflamasında Belirlenen Alanlarda Sorun Yaşama Oranları ve Hizmet Gereksinimleri
- 25 August 2021
- Published by Istanbul University in Experimed
- Vol. 11 (2) , 102-112
Open AccessAşırı Düşük Doğum Ağırlıklı Prematüre Çocukların Okul Öncesi Dönemde Dünya Sağlık Örgütü Çocuk ve Ergenlerde Uluslararası İşlevsellik Sınıflamasında Belirlenen Alanlarda Sorun Yaşama Oranları ve Hizmet Gereksinimleri
- 25 February 2015
- Published by Wiley in Pediatrics International
- Vol. 57 (1) , 177-179
Congenital nephrotic syndrome of NPHS1 associated with cardiac malformation
Congenital nephrotic syndrome (CNS) is a rare disease inherited as an autosomally recessive trait and defined as proteinuria manifesting at birth or in the first 3 months of life. The classical form is the Finnish type of CNS (CNF), which is caused by mutations in the nephrin gene (NPHS1). The classical findings include prematurity, large placenta and massive proteinuria. Minor cardiac findings have been reported as a minor functional disorder but CNS with major cardiac malformation is rare. Here we report the case of a Turkish child with CNS with small indel mutation (c.614_621delCACCCCGGinsTT) in exon 6 of NPHS1 and also major cardiac malformation who did not develop end‐stage renal disease until the age of 5 years.
- 25 February 2015
- Published by Wiley in Pediatrics International
- Vol. 57 (1) , 177-179
Congenital nephrotic syndrome of NPHS1 associated with cardiac malformation
Congenital nephrotic syndrome (CNS) is a rare disease inherited as an autosomally recessive trait and defined as proteinuria manifesting at birth or in the first 3 months of life. The classical form is the Finnish type of CNS (CNF), which is caused by mutations in the nephrin gene (NPHS1). The classical findings include prematurity, large placenta and massive proteinuria. Minor cardiac findings have been reported as a minor functional disorder but CNS with major cardiac malformation is rare. Here we report the case of a Turkish child with CNS with small indel mutation (c.614_621delCACCCCGGinsTT) in exon 6 of NPHS1 and also major cardiac malformation who did not develop end‐stage renal disease until the age of 5 years.